Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/psychiatric-medication-induced-obesity-an-aetiologic-review-0xnWgvvRng
References (53)
-
Guntram Schernthaner, Rudolf Prager, C. Punzengruber, Anton Luger (1985)
Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivoDiabetologia, 28
-
Y. Sugimoto, J. Yamada, T. Yoshikawa, T. Noma, K. Horisaka (1996)
Effects of peripheral 5-HT2 and 5-HT3 receptor agonists on food intake in food-deprived and 2-deoxy-D-glucose-treated rats.European journal of pharmacology, 316 1
-
M. Bickerdike, S. Vickers, C. Dourish (1999)
5‐HT2C receptor modulation and the treatment of obesityDiabetes, 1
-
Toru Kobayashi, K. Ikeda, T. Kumanishi (1998)
Effects of clozapine on the δ‐ and κ‐opioid receptors and the G‐protein‐activated K+ (GIRK) channel expressed in Xenopus oocytesBritish Journal of Pharmacology, 123
-
T. Baptista, D. Reyes, L. Hernández (1999)
Antipsychotic Drugs and Reproductive Hormones Relationship to Body Weight RegulationPharmacology Biochemistry and Behavior, 62
-
(1996)
Essential Psychopharmacology -
Stephen Stahl (1998)
Not so selective serotonin reuptake inhibitors.The Journal of clinical psychiatry, 59 7
-
AD Strosberg, F Pietri‐Rouxel (1996)
Function and regulation of beta‐3 adrenoceptorTrends Pharmacol Sci, 17
-
R Demura, M Ono, H Demura, K Shizume, H Oouchi (1982)
Prolactin directly inhibits basal as well as gonadotropin‐stimulated secretion of progesterone and 17 beta‐estradiol in the human ovaryFertil Steril, 54
-
J. Dorrington, R. Gore-Langton (1981)
Prolactin inhibits oestrogen synthesis in the ovaryNature, 290
-
P. Vendsborg, S. Prytz (1976)
GLUCOSE TOLERANCE AND SERUM LIPIDS INMAN AFTER LONG‐TERM LITHIUM ADMINISTRATIONActa Psychiatrica Scandinavica, 53
-
P. Vendsborg, P. Bech, O. Rafaelsen (1976)
LITHIUM TREATMENT AND WEIGHT GAINActa Psychiatrica Scandinavica, 53
-
Daniel Casey, Stevin Zorn (2001)
The pharmacology of weight gain with antipsychotics.The Journal of clinical psychiatry, 62 Suppl 7
-
G Luef, I Abraham, M Haslinger, E Trinka, K Seppi, I Unterberger, A Alge, J Windisch, M Lechleitner, G Bauer (2002)
Polycystic ovaries, obesity and insulin resistence in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 womenJ Clin Psych, 249
-
(1997)
Ziprasidone: a novel antipsychotic with unique pharmacology and therapeutic potential -
G. Luef, I. Abraham, M. Haslinger, E. Trinka, K. Seppi, I. Unterberger, A. Alge, J. Windisch, M. Lechleitner, G. Bauer (2002)
Polycystic ovaries, obesity and insulin resistance in women with epilepsyJournal of Neurology, 249
-
P Vendsberg, S Prytz (1976)
Glucose tolerance and serum lipids in man after long term lithium administrationPsychiatric Ann, 53
-
A. Strosberg, F. Piétri-Rouxel (1996)
Function and regulation of the 3-adrenoceptorTrends in Pharmacological Sciences
-
R. Demura, M. Ono, H. Demura, K. Shizume, H. Oouch (1982)
Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary.The Journal of clinical endocrinology and metabolism, 54 6
-
B. Harvey, C. Bouwer (2000)
Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake InhibitorsClinical Neuropharmacology, 23
-
TS Serger, PA Seymour, AW Schmidt, SH Zorn, DW Schulz, LA Lebel, S Mclean, V Guanowsky, HR Howard, JA III Lowe (1995)
Ziprasidone (CP 88.059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityJ Neurol, 275
-
(1998)
The novel antipsychotic ziprasidone has a unique human receptor binding profile compared to other agents -
L. Breum, A. Astrup, L. Gram, T. Andersen, K. Stokholm, N. Christensen, L. Werdelin, J. Madsen (1992)
Metabolic changes during treatment with valproate in humans: implication for untoward weight gain.Metabolism: clinical and experimental, 41 6
-
CD Bouwer, BH Harvey (1996)
Phasic craving for carbohydrates observed with citalopramActa Psychiatr Scand, 11
-
T Baptista, D Reyes, L Hernandez (1999)
Antipsychotic drugs and reproductive hormones: relationship to body weight regulationJ Clin Endocrinol Metab, 6
-
P. Sargent, A. Sharpley, C. Williams, E. Goodall, P. Cowen (1997)
5-HT2C receptor activation decreases appetite and body weight in obese subjectsPsychopharmacology, 133
-
D. Allison, D. Casey (2001)
Antipsychotic-induced weight gain: a review of the literature.The Journal of clinical psychiatry, 62 Suppl 7
-
P. Currie, D. Coscina (1998)
5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient 1 Published on the world wide web on 10 July 1998. 1Brain Research, 803
-
D. Gothelf, B. Falk, P. Singer, M. Kairi, M. Phillip, L. Zigel, I. Poraz, S. Frishman, N. Constantini, G. Zalsman, Abraham Weizman, A. Apter (2002)
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.The American journal of psychiatry, 159 6
-
A. Verrotti, F. Basciani, S. Morresi, M. Martino, G. Morgese, F. Chiarelli (1999)
Serum leptin changes in epileptic patients who gain weight after therapy with valproic acidNeurology, 53
-
T. Matsuzaki, K. Azuma, M. Irahara, T. Yasui, T. Aono (1994)
Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin.Fertility and sterility, 62 6
-
J. García-Sancho, J. Alvarez, M. Montero, C. Villalobos (1992)
Ca2+ influx following receptor activation.Trends in pharmacological sciences, 13 1
-
T. Sakata, H. Yoshimatsu, M. Kurokawa (1997)
Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism.Nutrition, 13 5
-
N. Sussman, D. Ginsberg (1999)
Effects of Psychotropic Drugs on WeightPsychiatric Annals, 29
-
Guy Goodwin (1996)
How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.The Journal of clinical psychiatry, 57 Suppl 4
-
T. Kraus, M. Haack, A. Schuld, D. Hinze‐Selch, Martin K�hn, M. Uhr, Thomas Pollm�cher (1999)
Body weight and leptin plasma levels during treatment with antipsychotic drugs.The American journal of psychiatry, 156 2
-
C. Bouwer, B. Harvey (1996)
Phasic craving for carbohydrate observed with citalopramInternational Clinical Psychopharmacology, 11
-
BH Harvey, CD Bouver (2000)
Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitorsDiabetes Obes Metab, 23
-
(1998)
Appetite suppression by commonly used drugs depends on 5HT availability -
E. Richelson (1996)
Preclinical pharmacology of neuroleptics: focus on new generation compounds.The Journal of clinical psychiatry, 57 Suppl 11
-
DE Casey, SH Zorn (2001)
The pharmacology of weight gain with antipsychoticsSoc Neurosci Abstract, 62
-
P. Masand (2000)
Weight gain associated with psychotropic drugsExpert Opinion on Pharmacotherapy, 1
-
D. Allison, Janet Mentore, Moonseong Heo, L. Chandler, J. Cappelleri, Ming Infante, P. Weiden (1999)
Antipsychotic-induced weight gain: a comprehensive research synthesis.The American journal of psychiatry, 156 11
-
T. Kobayashi, K. Ikeda, T. Kumanishi (1998)
Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.British journal of pharmacology, 123 3
-
Y Sugimoto, J Yamada, T Yoshikawa, T Noma, K Horisaka (1996)
Effects of peripheral 5HT2c and 5HT3 receptor agonists on food intake in food deprived and 2‐deoxy‐17‐glucose‐treated ratsBrain Res, 316
-
K Brady (1989)
Weight gain associated with psychotropic drugsJ Pharmacol Exp Ther, 82
-
T. Seeger, P. Seymour, Anne Schmidt, S. Zorn, D. Schulz, L. Lebel, S. Mclean, V. Guanowsky, H. Howard, J. Lowe (1995)
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.The Journal of pharmacology and experimental therapeutics, 275 1
-
P. Lambert, John Wilding, A. Al-Dokhayel, C. Bohuon, E. Comoy, S. Gilbey, S. Bloom (1993)
A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation.Endocrinology, 133 1
-
(1998)
Behavioral Neuroscience of Obesity -
E Richelson (1996)
Preclinical pharmacology of neuroleptics: focus on new generation compoundsClin Neuropharm, 57
-
M. Rietschel, D. Naber, R. Fimmers, H. Möller, P. Propping, M. Nöthen (1997)
Efficacy and side‐effects of clozapine not associated with variation in the 5‐HT2C receptorNeuroReport, 8
-
T. Baptista (1999)
Body weight gain induced by antipsychotic drugs: mechanisms and managementActa Psychiatrica Scandinavica, 100
-
G. Reynolds, Zhi-jun Zhang, Xiaobin Zhang (2002)
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphismThe Lancet, 359
- Publisher
- Wiley
- Copyright
- "Copyright © 2004 Wiley Subscription Services, Inc., A Wiley Company"
- ISSN
- 1467-7881
- eISSN
- 1467-789X
- DOI
- 10.1111/j.1467-789X.2004.00141.x
- pmid
- 15245385
- Publisher site
- See Article on Publisher Site
Abstract
A majority of psychiatric medications are known to generate weight gain and ultimately obesity in some patients. There is much speculation about the prevalence of weight gain and the degree of weight gain during acute and longitudinal treatment, but consensus shows that weight gain is prominent. The present review looked at the aetiology and cause of weight gain associated with psychotropic use and presents hypotheses as to why patients gain weight on antipsychotics, mood stabilizers and antidepressants. It is found that most psychotropic medications induce some weight gain, and clinicians are encouraged to utilize active interventions to alleviate the weight gain in order to prevent more serious obesity related comorbidities.
Journal
Obesity Reviews – Wiley
Published: Aug 1, 2004
Keywords: ; ; ;